As part of the disposal of MMS Communication LLC, the Group reached an agreement to buy back 100% of the Company’s share capital. This option is subject to a return to normal operating conditions, taking into account a five‑year exercise period starting on March 28, 2024. This period may be extended to 12 years, at the sole discretion of Publicis Groupe.
Given the current conditions, this call option has an insignificant value at the closing date.
The Group holds a call option on the remaining 50.11% of the capital of Core 1 WML, a media agency based in Ireland. The call option is valued at the market price according to the multiples method applied to the operating margin before amortization (as for the acquisition of 33.7% of the capital of Core 1 WML carried out in 2022). As the control premium does not represent a significant value, this purchase option has a zero value as of December 31, 2023.
As of December 31, 2023, there were no significant commitments such as pledges, guarantees or collateral, or any other significant off‑balance sheet commitments, in accordance with currently applicable accounting standards.
(in millions of euros) | Value in balance sheet | Fair value through profit and loss | Amortized cost | Fair value through OCI |
---|---|---|---|---|
Other financial assets | Other financial assets Value in balance sheet unspecified |
Other financial assets Fair value through profit and loss unspecified |
Other financial assets Amortized cost unspecified |
Other financial assets Fair value through OCI unspecified |
Venture Capital Funds |
Venture Capital Funds Value in balance sheet 144 |
Venture Capital Funds Fair value through profit and loss 144 |
Venture Capital Funds Amortized cost - |
Venture Capital Funds Fair value through OCI - |
Unconsolidated securities |
Unconsolidated securities Value in balance sheet 11 |
Unconsolidated securities Fair value through profit and loss 11 |
Unconsolidated securities Amortized cost - |
Unconsolidated securities Fair value through OCI - |
Security deposits |
Security deposits Value in balance sheet 43 |
Security deposits Fair value through profit and loss - |
Security deposits Amortized cost 43 |
Security deposits Fair value through OCI - |
Loans to associates and non‑consolidated companies |
Loans to associates and non‑consolidated companies Value in balance sheet 30 |
Loans to associates and non‑consolidated companies Fair value through profit and loss - |
Loans to associates and non‑consolidated companies Amortized cost 30 |
Loans to associates and non‑consolidated companies Fair value through OCI - |
Sub‑lease receivables |
Sub‑lease receivables Value in balance sheet 32 |
Sub‑lease receivables Fair value through profit and loss - |
Sub‑lease receivables Amortized cost 32 |
Sub‑lease receivables Fair value through OCI - |
Surplus of plan assets for pension commitments |
Surplus of plan assets for pension commitments Value in balance sheet 35 |
Surplus of plan assets for pension commitments Fair value through profit and loss - |
Surplus of plan assets for pension commitments Amortized cost - |
Surplus of plan assets for pension commitments Fair value through OCI 35 |
Other |
Other Value in balance sheet 21 |
Other Fair value through profit and loss - |
Other Amortized cost 21 |
Other Fair value through OCI - |
Trade receivables | Trade receivables Value in balance sheet 13,400 |
Trade receivables Fair value through profit and loss - |
Trade receivables Amortized cost 13,400 |
Trade receivables Fair value through OCI - |
Contract assets | Contract assets Value in balance sheet 1,297 |
Contract assets Fair value through profit and loss - |
Contract assets Amortized cost 1,297 |
Contract assets Fair value through OCI - |
Other receivables and current assets (1) | Other receivables and current assets (1) Value in balance sheet unspecified |
Other receivables and current assets (1) Fair value through profit and loss unspecified |
Other receivables and current assets (1) Amortized cost unspecified |
Other receivables and current assets (1) Fair value through OCI unspecified |
Derivatives hedging current assets and liabilities |
Derivatives hedging current assets and liabilities Value in balance sheet 3 |
Derivatives hedging current assets and liabilities Fair value through profit and loss 3 |
Derivatives hedging current assets and liabilities Amortized cost - |
Derivatives hedging current assets and liabilities Fair value through OCI - |
Derivatives hedging intercompany loans and borrowings |
Derivatives hedging intercompany loans and borrowings Value in balance sheet 6 |
Derivatives hedging intercompany loans and borrowings Fair value through profit and loss 6 |
Derivatives hedging intercompany loans and borrowings Amortized cost - |
Derivatives hedging intercompany loans and borrowings Fair value through OCI - |
Other receivables and current assets |
Other receivables and current assets Value in balance sheet 414 |
Other receivables and current assets Fair value through profit and loss - |
Other receivables and current assets Amortized cost 414 |
Other receivables and current assets Fair value through OCI - |
Cash and cash equivalents | Cash and cash equivalents Value in balance sheet 4,250 |
Cash and cash equivalents Fair value through profit and loss 2,610 |
Cash and cash equivalents Amortized cost 1,640 |
Cash and cash equivalents Fair value through OCI - |
Total financial instruments – assets | Total financial instruments – assets Value in balance sheet 19,686 |
Total financial instruments – assets Fair value through profit and loss 2,774 |
Total financial instruments – assets Amortized cost 16,877 |
Total financial instruments – assets Fair value through OCI 35 |
Long‑term borrowings | Long‑term borrowings Value in balance sheet 2,462 |
Long‑term borrowings Fair value through profit and loss 205 |
Long‑term borrowings Amortized cost 2,257 |
Long‑term borrowings Fair value through OCI - |
Trade payables | Trade payables Value in balance sheet 17,077 |
Trade payables Fair value through profit and loss - |
Trade payables Amortized cost 17,077 |
Trade payables Fair value through OCI - |
Short‑term borrowings | Short‑term borrowings Value in balance sheet 726 |
Short‑term borrowings Fair value through profit and loss 48 |
Short‑term borrowings Amortized cost 678 |
Short‑term borrowings Fair value through OCI - |
Other creditors and current liabilities (2) | Other creditors and current liabilities (2) Value in balance sheet unspecified |
Other creditors and current liabilities (2) Fair value through profit and loss unspecified |
Other creditors and current liabilities (2) Amortized cost unspecified |
Other creditors and current liabilities (2) Fair value through OCI unspecified |
Derivatives hedging current assets and liabilities |
Derivatives hedging current assets and liabilities Value in balance sheet 2 |
Derivatives hedging current assets and liabilities Fair value through profit and loss 2 |
Derivatives hedging current assets and liabilities Amortized cost - |
Derivatives hedging current assets and liabilities Fair value through OCI - |
Derivatives hedging intercompany loans and borrowings |
Derivatives hedging intercompany loans and borrowings Value in balance sheet 41 |
Derivatives hedging intercompany loans and borrowings Fair value through profit and loss 41 |
Derivatives hedging intercompany loans and borrowings Amortized cost - |
Derivatives hedging intercompany loans and borrowings Fair value through OCI - |
Derivatives hedging Eurobond 2025, 2028 and 2031 |
Derivatives hedging Eurobond 2025, 2028 and 2031 Value in balance sheet 117 |
Derivatives hedging Eurobond 2025, 2028 and 2031 Fair value through profit and loss - |
Derivatives hedging Eurobond 2025, 2028 and 2031 Amortized cost - |
Derivatives hedging Eurobond 2025, 2028 and 2031 Fair value through OCI 117 |
Other current liabilities |
Other current liabilities Value in balance sheet 413 |
Other current liabilities Fair value through profit and loss - |
Other current liabilities Amortized cost 413 |
Other current liabilities Fair value through OCI - |
Total financial instruments – liabilities | Total financial instruments – liabilities Value in balance sheet 20,838 |
Total financial instruments – liabilities Fair value through profit and loss 296 |
Total financial instruments – liabilities Amortized cost 20,425 |
Total financial instruments – liabilities Fair value through OCI 117 |